Sustained release formulation comprising bisphosphonate

Details for Australian Patent Application No. 2005318454 (hide)

Owner Novartis AG

Inventors Lambert, Olivier

Agent Davies Collison Cave

Pub. Number AU-B-2005318454

PCT Pub. Number WO2006/066868

Priority 0428151.5 22.12.04 GB

Filing date 20 December 2005

Wipo publication date 29 June 2006

Acceptance publication date 20 August 2009

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61P 5/02 (2006.01) Drugs for disorders of the endocrine system

Event Publications

14 June 2007 PCT application entered the National Phase

  PCT publication WO2006/066868 Priority application(s): WO2006/066868

20 August 2009 Application Accepted

  Published as AU-B-2005318454

17 December 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005318455-Contact lens design for large amplitude translation

2005318443-Process for the conversion of heavy charge stocks such as heavy crude oils and distillation residues